An increase in stroke risk factors over time without arrhythmia recurrence does not require restarting anticoagulation in low-risk atrial fibrillation patients after successful ablation. (RESTART-AF)

12 April 2026 (08:00 - 15:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Arne Ballet

ZAS Middelheim Heart Centre, Antwerp (Belgium)

5 More presentations in this session

Presentation thumbnail

Impact of coronary artery calcium score on the risk prediction for ischemic stroke in patients with atrial fibrillation

Mr Y. Lee (Kwang Ju, KR)

Abstract Slides Video

Presentation thumbnail

Stroke risk stratification by coronary artery disease extent in patients with atrial fibrillation

Associate Professor K. Lee (Gwangju, KR)

Abstract Slides Video

Presentation thumbnail

Incidence of left atrial thrombi in patients with atrial fibrillation and low thromboembolic risk: do we always need transesophageal echocardiography before rhythm control therapy?

Mr S. Koenig (Leipzig, DE)

Abstract Slides Video

Presentation thumbnail

Cause of death and competing risk in patients with device-detected atrial fibrillation treated with apixaban or aspirin: Insights from the ARTESiA trial

Doctor W. McIntyre (Hamilton, CA)

Abstract Slides Video

Presentation thumbnail

Loneliness as an independent predictor of long-term stroke risk in atrial fibrillation patients: a UK biobank cohort analysis

Doctor B. Li (Xi'an, CN)

Abstract Slides

Access the full session

Session thumbnail

Stroke in atrial fibrillation (2)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026

You may be interested in

Congress Session

Late-Breaking Clinical Science: stroke prevention

Congress Session

Atrial fibrillation: stroke - oral anticoagulants

Congress Session

Late-Breaking Science: paroxysmal atrial fibrillation ablation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources